The Economic Burden of Early-Stage Chronic Kidn...

By HEOR Staff Writer

January 18, 2024

The Silent Burden of Early-Stage CKD Chronic kidney disease (CKD) is a silent epidemic, affecting 9.1% of the global population. Both end-stage renal disease (ESKD) and cardiovascul...
Direct Oral Anticoagulants Efficacy Versus Vitamin K Antagonists
ISPOR’s Top 10 HEOR Trends for 2024-2025
Antimicrobial Resistance Cost in Two Ghanaian Hospitals
The Power of Prevention: The Untapped Potential of Adult Immunisation Programmes
A Closer Look at Global Health Research and Development
NICE’s Preparations for Evaluating New Alzheimer’s Treatments
The Future of Clinical Trials: A Shift from Artificial to Augmented to Applie...
Reassessing the Impact of Demographic Representation on Clinical Development ...
The Power of Public Health: A Look at South Africa’s HIV Treatment Prog...
The National Health Insurance Bill: Passed at NCOP
The Changing Landscape of Medicaid Managed Care Trends
Navigating the Maze: The EU Pharma Legislation Review and its Implications